• Issue

    Medicine Advances: Volume 2, Issue 1

    i-vi, 1-99
    March 2024

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: i-vi
  • First Published: 29 March 2024

REVIEW

Open Access

Modifying the electrical, optical, and magnetic properties of cancer cells: A comprehensive approach for cancer management

  • Pages: 3-19
  • First Published: 08 March 2024
Modifying the electrical, optical, and magnetic properties of cancer cells: A comprehensive approach for cancer management

“Factors modulate cancer cell properties”. Physical, chemical and magnetic properties modulate cancer cell properties.

Open Access

Quality of life, adherence and knowledge of epileptic patients and the impact of a pharmacist-led educational intervention: A review

  • Pages: 29-42
  • First Published: 19 March 2024
Quality of life, adherence and knowledge of epileptic patients and the impact of a pharmacist-led educational intervention: A review

Quality of Life, Adherence and Knowledge of Epileptic Patients and the Impact of a Pharmacist-Led Educational Intervention: A Review.

ORIGINAL ARTICLE

Open Access

Coffee and caffeine consumption and risk of periodontitis: National Health and Nutrition Examination Survey 2009–2014

  • Pages: 70-81
  • First Published: 08 March 2024
Coffee and caffeine consumption and risk of periodontitis: National Health and Nutrition Examination Survey 2009–2014

On the basis of the population data from the National Health and Nutrition Examination Survey (NHANES), negative correlations between the consumption of coffee or caffeine and the risk of periodontitis are revealed. Simultaneously, little evidence supports a latent association between coffee consumption and periodontitis. Therefore, as far as periodontitis is concerned, we could take into account the beneficial effects of coffee and other beverages containing caffeine.

Open Access

Chinese collaborative study of survival analysis in 980 patients with AL amyloidosis

  • Pages: 82-94
  • First Published: 25 March 2024
Chinese collaborative study of survival analysis in 980 patients with AL amyloidosis

The study presents a novel staging model leveraging NT-proBNP thresholds and eGFR levels, which surpasses existing models in predicting overall survival among AL amyloidosis patients. This innovative approach provides clinicians with an enhanced tool for accurately stratifying patient risk and guiding treatment decisions in this complex disease. Overall, the findings highlight significant advancements in prognostic assessment and underscore the importance of tailored management strategies in improving patient outcomes.